These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1327415

  • 1. A correlative study of calcium channel antagonist binding and local neuropathological features in the hippocampus in Alzheimer's disease.
    Ikeda M, Dewar D, McCulloch J.
    Brain Res; 1992 Sep 04; 589(2):313-9. PubMed ID: 1327415
    [Abstract] [Full Text] [Related]

  • 2. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O'Neill C.
    Neuroscience; 1999 Sep 04; 92(2):499-513. PubMed ID: 10408600
    [Abstract] [Full Text] [Related]

  • 3. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J, Brunner LC, Geddes JW, Choe W, Cotman CW.
    Neuroscience; 1992 Jul 04; 49(1):45-61. PubMed ID: 1407551
    [Abstract] [Full Text] [Related]

  • 4. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    Bonkale WL, Cowburn RF, Ohm TG, Bogdanovic N, Fastbom J.
    Brain Res; 1999 Feb 13; 818(2):383-96. PubMed ID: 10082824
    [Abstract] [Full Text] [Related]

  • 5. Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease.
    Ikeda M, Dewar D, McCulloch J.
    Brain Res; 1993 Dec 10; 630(1-2):50-6. PubMed ID: 7509712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preservation of [125I]galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease.
    Ikeda M, Dewar D, McCulloch J.
    Brain Res; 1991 Dec 24; 568(1-2):303-6. PubMed ID: 1726069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective alterations of high affinity [3H]forskolin binding sites in Alzheimer's disease: a quantitative autoradiographic study.
    Dewar D, Horsburgh K, Graham DI, Brooks DN, McCulloch J.
    Brain Res; 1990 Mar 19; 511(2):241-8. PubMed ID: 2110494
    [Abstract] [Full Text] [Related]

  • 16. L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue.
    Coon AL, Wallace DR, Mactutus CF, Booze RM.
    Neurobiol Aging; 1999 Mar 19; 20(6):597-603. PubMed ID: 10674425
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.